Comparison of 3 Different Density Levobupivacaine Solutions + Fentanyl for Spinal Anaesthesia for Caesarean Delivery.
Comparison of the Efficacy of 3 Different Density Levobupivacaine Solutions + Fentanyl Applied Intrathecally for Spinal Anesthesia in Caesarean Delivery.
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
The investigator's aim is to compare the efficacy of 3 levobupivacaine solutions with different density on spinal anesthesia for caesarean delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jun 2014
Typical duration for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 14, 2019
CompletedFirst Posted
Study publicly available on registry
May 20, 2019
CompletedMay 20, 2019
May 1, 2019
2 years
May 14, 2019
May 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change of time to reach T10 sensory spinal block level at intraoperative period by pinprick test
time to reach T10 sensory block by pinprick test
Every 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia.In these evaluation periods, the sensory block will be recorded when the T10 is detected.
Spinal Block Quality by questioning
the intensity of spinal block will be evaluated via questioning the surgeon and the patient. the surgeon will grade the abdominal relaxivity as good, medium or poor The patient will evaluate spinal block analgesia quality as good, medium or poor.
At the end of surgery
Change the sensory block level at intraoperative period by pinprick test
the level of maximum sensory block by pinprick test
Every 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia. The highest measured level by pinprick test be recorded
time to reach maximum level of sensory block at intraoperative period by pinprick test
time to reach maximum level of sensory block by pinprick test
Every 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia. the time to reach the highest measured by pinprick test will be recorded.
Change over time at the level of sensory block at intraoperative period by pinprick test
time to two segment regression of maximum sensory block by pinprick test
Every 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia. The time to two segment regression of maximum sensory block by pinprick test will be recorded.
Change in motor block level from PACU to discharge
motor block recovery time by bromage scale
every 15 minutes until end of surgery and 30 minutes postoperatively up to 2 hours by Bromage Scale
Change to regression of sensory block by pinprick test
time to S2 regression of sensory block by pinprick test
In the postoperative period, changes in sensory block level will be recorded at 30 min intervals up to 2 hours
Secondary Outcomes (3)
Haemodynamic evaluation by mmHg for systolic , diastolic and mean arterial blood pressure
Every 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia. every 30 minutes up to 2 hours
Number of participants with postoperative complications ( head ache, back pain, numbness of lower extremity )by phone
on postoperative day 3 by phone.
evaluation of umbilical vein blood gas analysis
immediately after fetus delivery
Study Arms (4)
Plain Levobupivacaine (Chirocaine (% 0.5)
ACTIVE COMPARATORLevobupivacaine 8 mg (Chirocaine (% 0.5)) + 20 mcg fentanyl Chirocaine Plain
Levobupivacaine (Chirocaine % 0,75) + dextrose 40
ACTIVE COMPARATORLevobupivacaine 8 mg (Chirocaine % 0,75) + 20 mcg fentanyl + dextrose 40 Chirocaine Heavy 40
Levobupivacaine (Chirocaine % 0,75) + dextrose 60
ACTIVE COMPARATORLevobupivacaine 8 mg (Chirocaine % 0,75) + 20 mcg fentanyl + dextrose 60 Chirocaine Heavy 60
Levobupivacaine (Chirocaine % 0,75) + dextrose 80
ACTIVE COMPARATORLevobupivacaine 8 mg (Chirocaine % 0,75) + 20 mcg fentanyl + dextrose 80 Chirocaine Heavy 80
Interventions
Levobupivacaine 8 mg Chirocaine (% 0.5) +20 mcg fentanyl
Chirocaine (%0.75) + Dextrose 40 mg+20 mcg fentanyl
Chirocaine (%0.75) + Dextrose 60 mg+20 mcg fentanyl
Chirocaine (%0.75) + Dextrose 80 mg+20 mcg fentanyl
Eligibility Criteria
You may qualify if:
- ASA I-II
- Pregnancy at Term
- Scheduled for elective caesarean delivery
You may not qualify if:
- contraindication for spinal anesthesia
- drug allergy
- pregnancy related disorders (hypertension, placenta previa, fetal problems)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Ozlem Sagir, Assist. Prof
Balikesir University School of Medicine Department of Anesthesia and Reanimation
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated Professor
Study Record Dates
First Submitted
May 14, 2019
First Posted
May 20, 2019
Study Start
June 1, 2014
Primary Completion
June 1, 2016
Study Completion
August 1, 2016
Last Updated
May 20, 2019
Record last verified: 2019-05